 |
 |
---------- > From: Sharon & Jim LeBlanc <[log in to unmask]> > To: [log in to unmask] > Subject: Fifth References for Theory of Environmental Parkinsons - Pollutant Botulism - Clostridium Botulinum > Date: Monday, July 05, 1999 3:42 PM > > PMID 134650 Fatty Acid-Binding Protein 1, Liver; FABP1 - binds free fatty > acids, their CoA derivatives, bilirubin, organic anions, and other small > molecules. (Succinyl CoA and Pamilitoyl -CoA oxidase or retinoic acid) > PMID 152425 Fatty Acid Coenzyme A ligase, long-chain 1: FACL1, this enzyme > also known as palmitoyl-CoA ligase plas a key role in both the synthesis of > cellular lipids and the degradation of fatty acids. > PMID 10353249 Inhibition of caspase-1 slows dissease progression in a mouse > model of Huntington's disease. > PMID 10100031 Evidence of functional zinc deficiency in Parkinsons disease. > > Theory : N-nitrosodimethylamine from diesel and gas exhaust of N. Le Blanc > caused a retinoic mutation in his fraternal twins. His son who also worked > in a fish factory with more N-nitrosodimethylamine lost his CREB2 and > overproduction of cAMP caused his Parkinsons disease. His daughter, who > smoked, and was often in smoked filled rooms, got too much > N-nitrosodimethylurea and breast cancer. > This explains Environmental Parkinsons and its relationship to twins. > > I have more papers you can look at to explain how Parkinsons causes > Diabetes type two and Psoriasis, my husband has both. What I hope is that > you will contact Ligand Pharmaceuticals in San Diego California that has a > new drug Targretin that is for N-nitrosodimethylurea causes breast cancer, > diabetes, and psoriasis. It is a retinoid X agonist, activator, and I think > it will help Parkinsons disease until they can make more specific retinoid > products, say CREB1 for cancer and CREB2 for Parkinsons and RRE-1 and HR-1 > for Huntington's chorea. It would be most helpful since my family includes > Huntington's disease too. > > [log in to unmask] >